JAZZ PHARMACEUTICALS DENMARK APS

DK-1604 KØBENHAVN V

Finances

Share Ownership

Return on Equity

19,42 %

Current Ratio

1,59

Debt-to-Equity Ratio

Key figures (DKK)	2022	2021	2020	2019
Revenue	30 364 000	21 714 000	16 469 000	7 280 000
Net Income	1 973 000	560 000	1 541 000	−484 000
Total Assets	27 479 000	21 014 000	19 286 000	9 503 000
Total Equity	10 162 000	8 189 000	7 629 000	6 088 000

Income (DKK)	2022	2021	2020	2019
Revenue	30 364 000	21 714 000	16 469 000	7 280 000
Expenditure	26 977 000	20 845 000	14 302 000	7 644 000
Operating Profit	3 388 000	869 000	2 168 000	−364 000
Financial Income	0	0	0	0
Financial Costs	1 409 000	441 000	333 000	258 000
Financial Balance	−1 409 000	−441 000	−333 000	−258 000
Earnings Before Tax	1 979 000	428 000	1 835 000	−622 000
Tax	6 000	−133 000	294 000	−138 000
Net Income	1 973 000	560 000	1 541 000	−484 000

Balance (DKK)	2022	2021	2020	2019
Total Fixed Assets	0	0	331 000	196 000
Total Current Assets	27 479 000	21 014 000	18 955 000	9 307 000
Total Assets	27 479 000	21 014 000	19 286 000	9 503 000
Total Retained Equity	10 112 000	8 139 000	7 579 000	6 038 000
Total Equity	10 162 000	8 189 000	7 629 000	6 088 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	17 317 000	12 825 000	11 657 000	3 415 000
Total Equity and Debt	27 479 000	21 014 000	19 286 000	9 503 000

Cash flow (DKK)	2022	2021	2020	2019
Sales Income	30 364 000	21 714 000	16 469 000	7 280 000
Other Income	0	0	0	0
Revenue	30 364 000	21 714 000	16 469 000	7 280 000
Cost of Goods Sold	0	0	0	0
Salary Costs	26 977 000	20 845 000	14 302 000	7 644 000
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	26 977 000	20 845 000	14 302 000	7 644 000
Operating Profit	3 388 000	869 000	2 168 000	−364 000
Financial Income	0	0	0	0
Financial Costs	1 409 000	441 000	333 000	258 000
Financial Balance	−1 409 000	−441 000	−333 000	−258 000
Dividends	0	0	0	0
Net Income	1 973 000	560 000	1 541 000	−484 000

Balance details (DKK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	331 000	196 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	331 000	196 000
Stock	8 167 000	4 388 000	7 129 000	0
Total Investments	0	0	0	0
Cash, Bank	1 447 000	2 261 000	1 853 000	2 502 000
Total Current Assets	27 479 000	21 014 000	18 955 000	9 307 000
Total Assets	27 479 000	21 014 000	19 286 000	9 503 000
Total Equity	10 162 000	8 189 000	7 629 000	6 088 000
Short-Term Group Debt	9 225 000	5 374 000	4 138 000	0
Total Long-Term Debt	0	0	0	0
Creditors	2 911 000	1 808 000	2 042 000	877 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	0	0
Other Current Debt	5 181 000	5 643 000	5 478 000	2 539 000
Total Current Debt	17 317 000	12 825 000	11 657 000	3 415 000
Total Equity and Debt	27 479 000	21 014 000	19 286 000	9 503 000

Financial indicators	2022	2021	2020	2019
Return on Equity	19,42 %	6,84 %	20,2 %	−7,95 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	11,16 %	4 %	13,16 %	−5 %
Current Ratio	1,59	1,64	1,63	2,73
Quick Ratio	3	2,49	4,19	2,73
Equity Ratio	0,37	0,39	0,4	0,64
Gross Profit Margin	100 %	100 %	100 %	100 %

Rotate your device to see the full table